CYP2J2 Targeting to Endothelial Cells Attenuates Adiposity and Vascular Dysfunction in Mice Fed a High-Fat Diet by Reprogramming Adipocyte Phenotype

CYP2J3 Gene Delivery Up-Regulated Adiponectin Expression via Reduced Endoplasmic Reticulum Stress in Adipocytes

(2013) Xizhen Xu et al.   ENDOCRINOLOGY

Roles of the epoxygenase CYP2J2 in the endothelium

(2013) Ara Askari et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction

(2013) Ping Gu et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt signaling cascade

(2013) Luca Vanella et al.   Stem Cell Research & Therapy

Endothelial Progenitor Cell Function Inversely Correlates With Long-term Glucose Control in Diabetic Patients: Association With the Attenuation of the Heme Oxygenase-Adiponectin Axis

(2012) Yossi Issan et al.   CANADIAN JOURNAL OF CARDIOLOGY

Mechanism of Fatty-Acid-Dependent UCP1 Uncoupling in Brown Fat Mitochondria

(2012) Andriy Fedorenko et al.   CELL

Heme Oxygenase Gene Targeting to Adipocytes Attenuates Adiposity and Vascular Dysfunction in Mice Fed a High-Fat Diet

(2012) Jian Cao et al.   HYPERTENSION

20-Iodo-14,15-epoxyeicosa-8(Z)-enoyl-3-azidophenylsulfonamide: Photoaffinity Labeling of a 14,15-Epoxyeicosatrienoic Acid Receptor

(2011) Yuenmu Chen et al.   BIOCHEMISTRY

Mechanisms linking obesity to hypertension

(2011) J. A. N. Dorresteijn et al.   Obesity Reviews

Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes

(2011) Luca Vanella et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Epoxyeicosatrienoic acids and heme oxygenase-1 interaction attenuates diabetes and metabolic syndrome complications

(2011) Angela Burgess et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels

(2011) Komal Sodhi et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Increased CYP2J3 Expression Reduces Insulin Resistance in Fructose-Treated Rats and db/db Mice

(2010) X. Xu et al.   DIABETES

Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice

(2010) Craig R. Lee et al.   FASEB JOURNAL

Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice

(2010) Yangmei Deng et al.   FASEB JOURNAL

Lentiviral-Human Heme Oxygenase Targeting Endothelium Improved Vascular Function in Angiotensin II Animal Model of Hypertension

(2010) Jian Cao et al.   HUMAN GENE THERAPY

Adipocyte Heme Oxygenase-1 Induction Attenuates Metabolic Syndrome in Both Male and Female Obese Mice

(2010) Angela Burgess et al.   HYPERTENSION

Epoxyeicosatrienoic Acid Agonist Regulates Human Mesenchymal Stem Cell–Derived Adipocytes Through Activation of HO-1-pAKT Signaling and a Decrease in PPARγ

(2010) Dong Hyun Kim et al.   STEM CELLS AND DEVELOPMENT

Heme Oxygenase-1 Induction Remodels Adipose Tissue and Improves Insulin Sensitivity in Obesity-Induced Diabetic Rats

(2009) Angelique Nicolai et al.   HYPERTENSION

The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice,

(2009) Stephen J. Peterson et al.   JOURNAL OF LIPID RESEARCH

Epoxyeicosatrienoic Acid Agonist Rescues the Metabolic Syndrome Phenotype of HO-2-Null Mice

(2009) K. Sodhi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

High-density lipoproteins, inflammation and oxidative stress

(2008) Fatiha Tabet et al.   CLINICAL SCIENCE

Treatment of Obese Diabetic Mice With a Heme Oxygenase Inducer Reduces Visceral and Subcutaneous Adiposity, Increases Adiponectin Levels, and Improves Insulin Sensitivity and Glucose Tolerance

(2008) M. Li et al.   DIABETES

Eicosanoids and renal damage in cardiometabolic syndrome

(2008) John D Imig   Expert Opinion on Drug Metabolism & Toxicology

L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice

(2008) Stephen J. Peterson et al.   JOURNAL OF LIPID RESEARCH

Pharmacological and Clinical Aspects of Heme Oxygenase

(2008) N. G. Abraham et al.   PHARMACOLOGICAL REVIEWS